You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,578,578


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,578,578
Title: Ophthalmic solutions
Abstract:Disclosed are solutions useful in surgery comprising a viscous or viscoelastic substance in an aqueous vehicle which is characterized as physiologically compatible; also disclosed are methods of using such solutions, implanting such viscous or viscoelastic substances, while minimizing the traumatic effect of surgery at the cellular level.
Inventor(s): Hecht; Gerald (Fort Worth, TX), Lorenzetti; Ole J. (Fort Worth, TX)
Assignee: Alcon Laboratories, Inc. (Fort Worth, TX)
Application Number:08/425,132
Patent Claim Types:
see list of patent claims
Formulation; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,578,578: A Comprehensive Analysis

Introduction

When analyzing a patent, particularly one like United States Patent 5,578,578, it is crucial to delve into its scope, claims, and the broader patent landscape. This analysis helps in understanding the patent's significance, its position within the industry, and potential legal and strategic implications.

Patent Overview

United States Patent 5,578,578, though not specifically detailed in the provided sources, can be analyzed using general principles of patent law and landscape analysis.

Patent Claims

Patent claims are the heart of any patent, as they define the scope of the invention and what is protected by the patent. Here are some key points to consider:

Claim Structure

  • Claims must "particularly point out" and "distinctly claim" the subject matter of the invention[5].
  • They should be clear and definite to avoid being found invalid as indefinite[5].

Subjective Claims Terms

  • When drafting patents, especially those with subjective claims terms, it is essential to provide numerous and meaningful examples to clarify the scope of the invention[5].
  • The courts aim to strike a balance between the inherent limitations of language and the need for clear notice of what is claimed[5].

Patent Scope

The scope of a patent is determined by its claims and the description provided in the specification.

Technology Field

  • Identify the technology field in which the patent operates. This could be one of the broad categories such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, or a miscellaneous “Other” category[1].

Inventor and Assignee

  • Determine the origin of the patent application (U.S. or foreign) based on the address of the first named inventor[1].
  • Identify whether the application was filed by a “large” or “small” entity, which can affect fees and other procedural aspects[1].

Patent Landscape Analysis

To understand the position of U.S. Patent 5,578,578 within the broader patent landscape, follow these steps:

Define Scope and Keywords

  • Define the technology field and specific terms that best represent the patent. Use these keywords to search for relevant patents in databases[3].

Search and Organize Patents

  • Use patent databases to find patents related to the keywords. Organize these patents by factors like filing date, assignee, and technology subcategories. Visual aids like heat maps can be useful[3].

Identify Trends and Key Players

  • Recognize patterns in patent filings and pinpoint significant contributors in the field. This helps in identifying competitors and potential collaborators[3].

Analyze Citations and Evolution

  • Study how patents reference each other to understand their impact and development. This can reveal the evolutionary path of the technology and the influence of the patent in question[3].

Generate Insights for Decisions

  • Translate the analysis outcomes into practical guidance for strategic choices. Evaluate the competitive landscape and potential legal vulnerabilities to inform business decisions[3].

Legal Considerations

Provisional Rights

  • If the patent was published before issuance, consider the provisional rights under 35 U.S.C. § 154(d). This allows patentees to collect a reasonable royalty from infringers who had actual notice of the published patent application and used the claimed invention before the patent issued[2].

Actual Notice Requirement

  • For provisional rights to apply, the infringing party must have had actual notice of the published patent application. Constructive notice is not sufficient, as clarified by the Federal Circuit in Rosebud LMS Inc. v. Adobe Systems Inc.[2].

Obviousness

  • The Federal Circuit's recent decision in LKQ Corp. v. GM Global Tech Operations LLC has changed the landscape for design patent obviousness. The rigid Rosen-Durling test has been discarded in favor of a more flexible approach, aligning with the principles set forth in KSR v. Teleflex[4].

Strategic Implications

Competitive Analysis

  • Understanding the patent landscape helps in competitive analysis. It reveals who the key players are, what technologies are being developed, and where there are gaps or opportunities for innovation[3].

Legal Vulnerabilities

  • Analyzing the patent landscape also helps in identifying potential legal vulnerabilities. This includes understanding the obviousness of the patent, the strength of its claims, and any potential challenges from competitors[3].

Case Studies and Examples

Rosebud LMS Inc. v. Adobe Systems Inc.

  • This case highlights the importance of actual notice in provisional rights. Rosebud’s failure to provide actual notice to Adobe resulted in the denial of provisional rights, even though Adobe had knowledge of related patents[2].

LKQ Corp. v. GM Global Tech Operations LLC

  • This decision illustrates the shift towards a more flexible approach in determining design patent obviousness. This change can impact the validity of existing design patents and the examination process for new applications[4].

Key Takeaways

  • Clear Claims: Ensure that patent claims are clear and definite to avoid invalidity.
  • Provisional Rights: Understand the requirements for provisional rights, including actual notice and substantially identical claims.
  • Obviousness: Be aware of the evolving standards for obviousness, especially in design patents.
  • Landscape Analysis: Conduct thorough patent landscape analysis to understand competitive positioning and legal vulnerabilities.
  • Strategic Decisions: Use patent landscape analysis to inform strategic business decisions.

Frequently Asked Questions

Q: What is the importance of clear and definite claims in a patent?

A: Clear and definite claims are crucial because they define the scope of the invention and must meet the requirements of 35 USC 112(b) to avoid being found invalid as indefinite[5].

Q: How does the provisional rights provision under 35 U.S.C. § 154(d) work?

A: Provisional rights allow patentees to collect a reasonable royalty from infringers who had actual notice of the published patent application and used the claimed invention before the patent issued[2].

Q: What is the impact of the Federal Circuit's decision in LKQ Corp. v. GM Global Tech Operations LLC on design patent obviousness?

A: The decision discarded the rigid Rosen-Durling test and adopted a more flexible approach for determining design patent obviousness, aligning with the principles set forth in KSR v. Teleflex[4].

Q: Why is patent landscape analysis important for business strategy?

A: Patent landscape analysis helps in understanding the competitive landscape, identifying key players, recognizing trends, and informing strategic business decisions[3].

Q: How can one ensure that a patent application meets the requirements for provisional rights?

A: To ensure provisional rights, the patent application must be published, and the infringing party must have had actual notice of the published application. The claimed invention in both the published application and the issued patent must be substantially identical[2].

Cited Sources

  1. What Is the Probability of Receiving a US Patent? - Carley, M., & Hegde, D. (n.d.). Retrieved from https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  2. Preserving Provisional Rights for Pre-Issuance Patent Damages - Kramer Levin. (2018). Retrieved from https://www.kramerlevin.com/a/web/43719/preserving-provisional-rights-pre-issuance-patent-damages.pdf
  3. How to Do Patent Landscape Analysis - Goldstein Patent Law. (n.d.). Retrieved from https://www.goldsteinpatentlaw.com/how-to-patent-landscape-analysis/
  4. Full Federal Circuit Eliminates “Improperly Rigid” Tests for Design Patent Obviousness - Ballard Spahr. (2024). Retrieved from https://www.ballardspahr.com/insights/alerts-and-articles/2024/05/full-federal-circuit-eliminates-improperly-rigid-tests-for-design-patent-obviousness
  5. Practical Advice for Drafting Patents with Subjective Claims Terms - Buchanan Ingersoll & Rooney PC. (2017). Retrieved from https://www.bipc.com/practical-advice-for-drafting-patents-with-subjective-claims-terms

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,578,578

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,578,578

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2389595 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 9632929 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.